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Synthesis, characterization and mechanistic studies in search for 
structure-activity relationships 
 
 
1. NMR spectroscopy is a powerful tool, not only useful for the elucidation of 
structures, but also for conformational studies. 
This thesis 
 
2.  Not all ruthenium anticancer agents follow the same mechanism of action. 
This thesis 
 
3. Neither all ruthenium anticancer agents interact with DNA via coordination, nor all 
ruthenium agents capable of coordinating to DNA display anticancer activity. 
This thesis 
 
4. The study of the interactions between a potential ruthenium anticancer drug and 
serum transport proteins is of utmost importance. 
This thesis 
 
5. The repeated claims by Ochocki on the high anticancer activity of the complex 
cis-bis(3-aminoflavone)dichloroplatinum(II), comparable or even better than 
cisplatin, are questionable, as no valid characterization and purity of this complex, 
which is insoluble in water, are provided. 
Ochocki, J.; Zyner, E., PL. Patent No. P.185585 (2003). 
Kosminder, B.; Wojcik, I.; Osiecka, R.; Bartkowiak, J.; Zyner, E.; Ochocki, J.; 
Liberski, P.,  Invest. New Drugs 2005, 23, 287-297. 
Kosminder, B.; Zyner, E.; Osiecka, R.; Ochocki, J., Mutat. Res. Genet. Toxicol. 
Environ. Mutagen. 2004, 563, 61-70; and other articles. 
 
6. It is striking that a group that specializes in photoactive Ru(II) complexes composes 
a book chapter entitled “Perspectives of ruthenium complexes in cancer therapy”, in 
which the activity of the so-called mer-[Ru(II)(terpy)Cl3]- is discussed. Not only 
should the oxidation state of ruthenium be (III) and therefore the complex neutral, 
but the formula is correctly written in the references that are provided by the authors 
of the book chapter. 
Lentzen, O.; Moucheron, C.; Kirsch-De Mesmaeker, A.; Metallotherapeutic drugs 
& metal-based diagnostic agents. John Wiley & Sons, Ltd: West Sussex, 2005, 359-
378. 
Nováková, O.; Kaspárková, J.; Vrána, O.; van Vliet, P. M.; Reedijk, J.; Brabec, V., 
Biochemistry 1995, 34, 12369-12378. 
van Vliet, P. M.; Toekimin, S. M. S.; Haasnoot, J. G.; Reedijk, J.; Nováková, O.; 
Vrána, O.; Brabec, V., Inorg. Chim. Acta 1995, 231, 57-64. 
 
7. It is very unlikely that a solution 4% DMSO in H2O has absolutely no toxic effect in 
the tested cells. 
 Ma, D. L.; Che, C. M.; Siu, F. M.; Yang, M.; Wong, K. Y., Inorg. Chem. 2007, 46, 
740-749. 
 
8. Scientists tend to demand an exact, accurate use of scientific terms. In the 
meantime, they keep on misusing the words that are borrowed from everyday life. 
 Jansen, M.; Schön, J. C., Angew. Chem. Int. Ed. 2006, 45, 3406-3412. 
 
9. People working in multidisciplinary fields should speak the same language. For 
example, IC50 values given in ng/mL cannot be compared with these values given in 
μM, especially when heavy compounds, such as metallodrugs, are involved. 
 
10. When comparing the nutritional habits of two different societies, one always tends 
to believe that his own habits are healthy and the others are not. We easily overlook 
the fact that most people belonging to the other group are fit and happy. 
  
11. Being abroad makes us do weird things: from getting close to someone we would 
have never greeted in our hometown to watching the Eurovision song festival and 
actually enjoying it. 
 
12. How nice it would be if singers sang songs, football players played football and 
journalists gave the news. 
 
 
 
Eva Corral Simón 
Leiden, 25th September 2007 
